Literature DB >> 27458539

Macrolides for Acute Wheezing Episodes in Preschool Children.

Hengameh H Raissy1, Kathryn Blake2.   

Abstract

The National Asthma Education and Prevention Program's Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma does not recommend antibiotics for the management of acute episodes of asthma exacerbation. Macrolides seem to have some potential effect beyond or in addition to their antibacterial effect. It has been reported that macrolides may potentially benefit patients with chronic inflammatory airway diseases due to their antibacterial, antiviral, and/or anti-inflammatory effects. This review presents recent data on use of azithromycin in prevention and management of acute exacerbation of respiratory symptoms in infants and young children.

Entities:  

Year:  2016        PMID： 27458539      PMCID： PMC4926226          DOI： 10.1089/ped.2016.0663

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN： 2151-321X            Impact factor:   1.349


  33 in total

1.  The state of childhood asthma, United States, 1980-2005.

Authors:  Lara Akinbami
Journal:  Adv Data       Date:  2006-12-12

Review 2.  Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults.

Authors:  Peter W Heymann; Thomas A E Platts-Mills; Sebastian L Johnston
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

3.  Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.

Authors:  Guy G Brusselle; Christine Vanderstichele; Paul Jordens; René Deman; Hans Slabbynck; Veerle Ringoet; Geert Verleden; Ingel K Demedts; Katia Verhamme; Anja Delporte; Bénédicte Demeyere; Geert Claeys; Jerina Boelens; Elizaveta Padalko; Johny Verschakelen; Georges Van Maele; Ellen Deschepper; Guy F P Joos
Journal:  Thorax       Date:  2013-01-03       Impact factor: 9.139

4.  Azithromycin induces anti-viral responses in bronchial epithelial cells.

Authors:  V Gielen; S L Johnston; M R Edwards
Journal:  Eur Respir J       Date:  2010-02-11       Impact factor: 16.671

5.  Rhinovirus activates interleukin-8 expression via a Src/p110beta phosphatidylinositol 3-kinase/Akt pathway in human airway epithelial cells.

Authors:  J Kelley Bentley; Dawn C Newcomb; Adam M Goldsmith; Yue Jia; Uma S Sajjan; Marc B Hershenson
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

Review 6.  Therapy with macrolides in patients with cystic fibrosis.

Authors:  Allyson S Gaylor; Joan C Reilly
Journal:  Pharmacotherapy       Date:  2002-02       Impact factor: 4.705

7.  Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial.

Authors:  Leonard B Bacharier; Theresa W Guilbert; David T Mauger; Susan Boehmer; Avraham Beigelman; Anne M Fitzpatrick; Daniel J Jackson; Sachin N Baxi; Mindy Benson; Carey-Ann D Burnham; Michael Cabana; Mario Castro; James F Chmiel; Ronina Covar; Michael Daines; Jonathan M Gaffin; Deborah Ann Gentile; Fernando Holguin; Elliot Israel; H William Kelly; Stephen C Lazarus; Robert F Lemanske; Ngoc Ly; Kelley Meade; Wayne Morgan; James Moy; Tod Olin; Stephen P Peters; Wanda Phipatanakul; Jacqueline A Pongracic; Hengameh H Raissy; Kristie Ross; William J Sheehan; Christine Sorkness; Stanley J Szefler; W Gerald Teague; Shannon Thyne; Fernando D Martinez
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

8.  Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.

Authors:  O Sakito; J Kadota; S Kohno; K Abe; R Shirai; K Hara
Journal:  Respiration       Date:  1996       Impact factor: 3.580

9.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.

Authors:  H Nagai; H Shishido; R Yoneda; E Yamaguchi; A Tamura; A Kurashima
Journal:  Respiration       Date:  1991       Impact factor: 3.580

10.  Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial.

Authors:  Jakob Stokholm; Bo L Chawes; Nadja H Vissing; Elín Bjarnadóttir; Tine M Pedersen; Rebecca K Vinding; Ann-Marie M Schoos; Helene M Wolsk; Sunna Thorsteinsdóttir; Henrik W Hallas; Lambang Arianto; Susanne Schjørring; Karen A Krogfelt; Thea K Fischer; Christian B Pipper; Klaus Bønnelykke; Hans Bisgaard
Journal:  Lancet Respir Med       Date:  2015-12-17       Impact factor: 30.700
View more
  2 in total

1.  Emerging Therapies in the Treatment of Early Childhood Wheeze.

Authors:  Elissa M Abrams; Hengameh H Raissy
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-06-17       Impact factor: 1.349

Review 2.  Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review.

Authors:  Jef Willems; Eline Hermans; Petra Schelstraete; Pieter Depuydt; Pieter De Cock
Journal:  Paediatr Drugs       Date:  2020-11-10       Impact factor: 3.022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.